论文部分内容阅读
目的:对哮喘患儿使用孟鲁司特钠的临床治疗效果作出分析和总结。方法:选取在我院接受治疗的80例哮喘患儿为研究对象,其入院接受治疗的时间段为2014年1月至2016年12月,通过随机数字法将患儿单位数据样本设为X组(观察组)和Y组(对照组),每组各40例。给予Y组进行常规性药物治疗,则X组在基于Y组常规性药物治疗的基础之上,辅以孟鲁司特钠治疗,并对两组患儿的肺部机能的异动数据以及临床治疗效果进行记录并对比。结果:X组患儿在接受辅以孟鲁司特钠的治疗后其肺部机能数据和临床治疗效果显著优于仅进行常规性药物治疗的Y组患儿,统计学意义显著(P<0.05)。结论:对患有哮喘的患儿使用常规性药物治疗的基础之上,辅以孟鲁司特钠治疗,具有显著的临床治疗效果,值得在临床中推广使用。
Objective: To analyze and summarize the clinical effect of using montelukast sodium in children with asthma. Methods: Eighty asthmatic children treated in our hospital were enrolled in this study. The admission period for treatment was from January 2014 to December 2016. Randomized data were used to set the children’s unit data sample as group X (Observation group) and Y group (control group), 40 cases in each group. Group Y was given conventional drug treatment, then group X was based on the conventional Y group drug treatment, supplemented by montelukast sodium treatment, and the two groups of children with lung function abnormal changes in data and clinical treatment The effect is recorded and compared. Results: The data of lung function and clinical curative effect in group X were significantly better than those in group Y only receiving routine drug treatment after receiving montelukast sodium. The statistical significance was significant (P <0.05 ). Conclusion: Based on the conventional drug therapy in children with asthma, the treatment with montelukast sodium has significant clinical effect and is worth popularizing in clinic.